About ProKidney
A Potential New Era in the Treatment of CKD
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Winston-Salem, North Carolina
- Company type
- Public Company
- Company profile name
- ProKidney Corp.
ProKidney, a pioneer in the treatment of chronic kidney disease through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, rilparencel (also known as REACT®), is a first-in-class, patented, proprietary autologous cellular therapy being evaluated in Phase 2 and Phase 3 studies for its potential to preserve kidney function in diabetic patients at high risk of kidney failure. Rilparencel has received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA. For more information, please visit www.prokidney.com.
Company locations
2000 Frontis Plaza Blvd, 250, Winston-Salem, North Carolina 27103, US
8020 Arco Corporate Dr, 400, Raleigh, North Carolina 27617, US
3929 Westpoint Blvd, Winston-Salem, North Carolina 27103, US
399 Boylston St, Boston, Massachusetts 02116, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Care
- Therapeutics
- Biotechnology
- Pharmaceutical and biotechnology
On LinkedIn
- Followers
- 10,180
- People linked to this company
- 235
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
345,000,000 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.